tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BFRI Stock Latest News

Biofrontera reports preliminary Q4 revenue $17M-$17.5M
The FlyBiofrontera reports preliminary Q4 revenue $17M-$17.5M
24d ago
BFRI
Biofrontera announces data base locks for two clinical studies
PremiumThe Fly
Biofrontera announces data base locks for two clinical studies
29d ago
BFRI
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
PremiumCompany Announcements
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
1M ago
8K
BFRI
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
PremiumThe Fly
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
2M ago
BFRI
Biofrontera Inc. files to sell 4M shares of common stock for holders
PremiumThe Fly
Biofrontera Inc. files to sell 4M shares of common stock for holders
2M ago
BFRI
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
PremiumThe FlyBiofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
2M ago
BFRI
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC
Premium
The Fly
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC
2M ago
BFRI
Biofrontera Inc. Reports Q3 2025 Results and Strategic Moves
Premium
Company Announcements
Biofrontera Inc. Reports Q3 2025 Results and Strategic Moves
3M ago
BFRI
Biofrontera, Inc. Navigates Mixed Earnings Call
PremiumCompany Announcements
Biofrontera, Inc. Navigates Mixed Earnings Call
3M ago
BFRI
Biofrontera reports Q3 EPS (62c) vs (98c) last year
PremiumThe Fly
Biofrontera reports Q3 EPS (62c) vs (98c) last year
3M ago
BFRI
Biofrontera Regains Nasdaq Compliance in November 2025
PremiumCompany Announcements
Biofrontera Regains Nasdaq Compliance in November 2025
3M ago
8K
BFRI
Roth views divestiture as ‘essentially found money’ for Biofrontera
PremiumThe Fly
Roth views divestiture as ‘essentially found money’ for Biofrontera
3M ago
BFRI
Biofrontera Completes Sale of Xepi US License
PremiumCompany AnnouncementsBiofrontera Completes Sale of Xepi US License
3M ago
8K
BFRI
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
Premium
The Fly
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
3M ago
BFRI
LGND
Biofrontera announces sale of license for Xepi Cream to Pelthos
Premium
The Fly
Biofrontera announces sale of license for Xepi Cream to Pelthos
3M ago
BFRI
PTHS
Biofrontera Finalizes U.S. Rights Acquisition Deal
PremiumCompany Announcements
Biofrontera Finalizes U.S. Rights Acquisition Deal
4M ago
8K
BFRI
Biofrontera Completes Restructuring and Asset Purchase
PremiumCompany Announcements
Biofrontera Completes Restructuring and Asset Purchase
4M ago
8K
BFRI
Biofrontera Inc. close purchase of all Ameluz, RhodoLED U.S. assets
PremiumThe Fly
Biofrontera Inc. close purchase of all Ameluz, RhodoLED U.S. assets
4M ago
BFRI
Biofrontera Inc. price target lowered to $9 from $10 at Roth Capital
PremiumThe Fly
Biofrontera Inc. price target lowered to $9 from $10 at Roth Capital
4M ago
BFRI
Biofrontera Approves Key Proposals at Special Meeting
PremiumCompany AnnouncementsBiofrontera Approves Key Proposals at Special Meeting
5M ago
8K
BFRI
Biofrontera says last patient completes treatment in Phase 3 study of Ameluz
Premium
The Fly
Biofrontera says last patient completes treatment in Phase 3 study of Ameluz
5M ago
BFRI
Biofrontera, Inc. Reports Record Sales Amid Strategic Growth
Premium
Company Announcements
Biofrontera, Inc. Reports Record Sales Amid Strategic Growth
5M ago
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >